(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of -1.25% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.64%.
Quidelortho's revenue in 2023 is $3,121,700,000.On average, 4 Wall Street analysts forecast QDEL's revenue for 2023 to be $204,026,946,290, with the lowest QDEL revenue forecast at $202,900,382,704, and the highest QDEL revenue forecast at $205,681,377,748. On average, 4 Wall Street analysts forecast QDEL's revenue for 2024 to be $197,283,734,907, with the lowest QDEL revenue forecast at $194,922,227,775, and the highest QDEL revenue forecast at $202,236,204,648.
In 2025, QDEL is forecast to generate $209,880,666,899 in revenue, with the lowest revenue forecast at $206,090,308,302 and the highest revenue forecast at $215,263,181,909.